E-LIB Suche - Ergebnisse für: Nitz, U.

1

121P Endocrine response assessment in HR+ HER2- early breas..:

Hamann, M. ; Gluz, O. ; Christgen, M....
ESMO Open. 9 (2024) - p. 103109 , 2024

Link: https://doi.org/10.1016/..

2

18P A translational project of the WSG-ADAPT-TN trial demon..:

Graeser, M. ; Harbeck, N. ; Gluz, O....
ESMO Open. 8 (2023) 1 - p. 101242 , 2023

Link: https://doi.org/10.1016/..

3

120TiP Premenopausal women with breast cancer optimally tre..:

Fischer, L.A. ; Gluz, O. ; Graeser, M....
ESMO Open. 8 (2023) 1 - p. 101344 , 2023

Link: https://doi.org/10.1016/..

4

109P Updated long-term overall survival of older adjuvant i..:

Schmidt, M. ; Nitz, U.A. ; Reimer, T....
ESMO Open. 8 (2023) 1 - p. 101333 , 2023

Link: https://doi.org/10.1016/..

5

Differential impact of prognostic parameters in hormone rec..:

Christgen, M. ; Harbeck, N. ; Gluz, O....
European Journal of Cancer. 138 (2020) - p. S1 , 2020

Link: https://doi.org/10.1016/..

6

ADAPTcycle – adjuvant dynamic marker-adjusted personalized ..:

Harbeck, N. ; Gluz, O. ; Christgen, M....
The Breast. 44 (2019) - p. S133 , 2019

Link: https://doi.org/10.1016/..

7

Chemotherapy (CT) decision in node-positive (N+), ER+, earl..:

Mamounas, E.P. ; Goldstein, L.J. ; Penault-Llorca, F....
The Breast. 32 (2017) - p. S98 , 2017

Link: https://doi.org/10.1016/..

8

Five-year results of the prospective Phase III WSG PlanB tr..:

Gluz, O. ; Nitz, U. ; Christgen, M....
The Breast. 32 (2017) - p. S93 , 2017

Link: https://doi.org/10.1016/..

9

Klinische Pathologie des Mammakarzinoms: Prognose und Prädi..:

Kreipe, H. ; Nitz, U.
Der Gynäkologe. 49 (2016) 10 - p. 737-745 , 2016

Link: https://doi.org/10.1007/..

10

P231 Luminal subtypes vs. early Ki-67 response and Oncotype..:

Gluz, O. ; Nitz, U. ; Christgen, M....
The Breast. 24 (2015) - p. S104-S105 , 2015

Link: https://doi.org/10.1016/..

11

Prädiktive Gensignaturen: Wie valide sind sie?:

Harbeck, N. ; Gluz, O. ; Nitz, U.
Forum. 30 (2015) 2 - p. 134-138 , 2015

Link: https://doi.org/10.1007/..

12

1937 Clinical impact of risk classification by central/loca..:

Gluz, O. ; Nitz, U. ; Kreipe, H.H....
European Journal of Cancer. 51 (2015) - p. S311 , 2015

Link: https://doi.org/10.1016/..

13

P246 Risk assessment by St.Gallen 2013 recommendation and O..:

Nitz, U. ; Christgen, O. Gluz,H. Kreipe,M. ; Clemens, R.E. Kates,M....
The Breast. 24 (2015) - p. S110 , 2015

Link: https://doi.org/10.1016/..

14

Response:

Moebus, V. ; Jackisch, C. ; Schneeweiss, A....
JNCI Journal of the National Cancer Institute. 106 (2014) 3 - p. djt452-djt452 , 2014

Link: https://doi.org/10.1093/..

15

Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemothe..:

Moebus, V. ; Jackisch, C. ; Schneeweiss, A....
JNCI Journal of the National Cancer Institute. 105 (2013) 14 - p. 1018-1026 , 2013

Link: https://doi.org/10.1093/..